Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: A prospective observational study
Annals of Intensive Care May 18, 2021
Hatzl S, Posch F, Sareban N, et al. - Researchers conducted this single-center prospective observational cohort study to assess the potential survival benefit of convalescent plasma therapy (CVP) in critically ill patients with acute respiratory failure caused by coronavirus disease-2019 (COVID-19). This investigation was carried out in COVID-19 patients with acute respiratory failure. One hundred twenty patients were enrolled, 48 of whom received CVP. CVP administration in patients with acute respiratory failure caused by COVID-19 is associated with improved ICU survival rates.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries